Rubedo Life Sciences Targets Actinic Keratoses with New Drug Approach
Rubedo Life Sciences has developed a new drug aimed at treating actinic keratoses (AK), a skin condition affecting millions. This innovative treatment seeks to prevent skin cancer by addressing the…